Aclaris Therapeutics, Inc. Human Resources Contracts & Agreements

Amended and Restated Employment Agreement, effective as of July 1, 2023, by and between the Company and Joseph Monahan (Filed With SEC on June 12, 2023)

Ninth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 8, 2023)

Amendment No. 1 to Consulting Services Agreement, dated as of March 23, 2023, by and between the Company and Frank Ruffo (Filed With SEC on March 27, 2023)

Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser (Filed With SEC on February 23, 2023)

Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion (Filed With SEC on February 23, 2023)

Consulting Agreement, dated as of January 1, 2023, by and between the Registrant and Frank Ruffo (Filed With SEC on February 23, 2023)

Separation Agreement and General Release, dated as of December 9, 2022, by and between the Registrant and Frank Ruffo (Filed With SEC on February 23, 2023)

Eighth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 23, 2023)

Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell (Filed With SEC on August 3, 2022)

Employment Agreement, dated as of August 1, 2022, by and between the Company and Douglas Manion (Filed With SEC on August 1, 2022)

Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)

Severance Agreement and General Release, dated as of January 7, 2022, by and between the Registrant and David Gordon (Filed With SEC on February 24, 2022)

Severance Agreement and General Release, dated as of November 1, 2021, by and between the Registrant and Kamil Ali-Jackson (Filed With SEC on February 24, 2022)

Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (Filed With SEC on February 24, 2022)

Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (Filed With SEC on February 24, 2022)

Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)

Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Neal Walker (Filed With SEC on January 14, 2022)

Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Frank Ruffo (Filed With SEC on January 14, 2022)

Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 5, 2021)

Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)

Change in Control Severance Benefit Plan, effective January 1, 2017, as amended by First Amendment to Change in Control Severance Benefit Plan, effective October 2, 2019 (Filed With SEC on February 25, 2021)

Employment Agreement with Frank Ruffo, dated as of September 17, 2015 (Filed With SEC on February 25, 2020)

Third Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)

Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)

Form of Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the 2015 Equity Incentive Plan (Filed With SEC on March 18, 2019)

Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan (Filed With SEC on March 18, 2019)

Amended & Restated Non-Employee Director Compensation Policy (Filed With SEC on March 18, 2019)

Seventh Amendment to Services Agreement between the Registrant and NST Consulting, LLC, dated as of May 11, 2017 (Filed With SEC on August 8, 2017)

Employment Agreement with Kamil Ali-Jackson, dated as of September 17, 2015 (Filed With SEC on May 9, 2017)

SIXTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC. (Filed With SEC on March 15, 2017)

THIRD AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC. (Filed With SEC on May 11, 2016)

FOURTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC. (Filed With SEC on May 11, 2016)

FIFTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC. (Filed With SEC on May 11, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on November 18, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on September 25, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on September 25, 2015)

ACLARIS THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on September 25, 2015)

ACLARIS THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on September 25, 2015)